Table 2.
No. | Approach | Resection | Indication for contralateral lung resection | Anesthesia technique | OP time (min) | Blood loss (mL) | Hospital days | Complication | Recurrence (interval after operation) (mo) | Additional treatment | Outcome | Survival (mo) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | VATS | Wedge (RLL) | Squamous cell carcinoma: pT1a | Lung down | 32 | 50 | 11 | AKI | - | - | Dead | 25 |
2 | Mini-thoracotomy | Wedge (RUL) | Adenocarcinoma: pT1a | Lung down | 73 | 100 | 7 | - | - | - | Alive | 76 |
3 | Mini-thoracotomy | Wedge (RUL) | Adenocarcinoma: pT3 | Lung down | 50 | 20 | 8 | - | Lower paratracheal & subcarinal LN (6) | CCRT | Alive | 49 |
4 | Mini-thoracotomy | Wedge ×2 (RML) | Adenoid cystic carcinoma | Blocker | 63 | 100 | 6 | Pneumothorax | RLL (5) | - | Alive | 41 |
5 | Thoracotomy | Wedge (RLL) | Squamous cell carcinoma: pT1b | Lung down | 29 | 20 | 4 | - | RLL, liver, bone (14) | RTx | Dead | 16 |
6 | Mini-thoracotomy | Wedge (RUL) | Squamous cell carcinoma: pT1a | Blocker | 62 | 50 | 6 | - | RLL (3) | RTx | Dead | 13 |
7 | Thoracotomy | Wedge (RLL) | Calcified granuloma | Lung down | 159 | 20 | 17 | Pneumonia; prolonged air leak | RLL (60) | - | Dead | 71 |
8 | Mini-thoracotomy | Wedge (LUL) | Angiosarcoma | Lung down | 45 | 20 | 11 | - | Carina LN (3) | CTx | Dead | 13 |
9 | Mini-thoracotomy | Wedge (RUL) | Osteosarcoma | Lung down | 66 | 50 | 8 | - | RLL (4) | Reoperation | Alive | 112 |
10 | VATS | Wedge (RLL) | Adenocarcinoma: pT1a | Lung down | 60 | 50 | 9 | - | - | - | Alive | 60 |
11 | Thoracotomy | Wedge (LUL, LLL) | Adenocarcinoma (colon ca metastasis) | Lung down | 51 | 20 | 15 | - | - | CTx | Dead | 76 |
12 | Thoracotomy | Lobectomy (RUL) | Tuberculosis | Lung down | 170 | 20 | 13 | - | MDR-TB | - | Alive | 231 |
13 | Thoracotomy | Wedge (LUL) | Tuberculosis | Lung down | 147 | 400 | 12 | Prolonged air leak | MDR-TB | - | Alive | 125 |
OP, operation; VATS, video-assisted thoracoscopic surgery; RLL, right lower lobe; AKI, acute kidney injury; RUL, right upper lobe; LN, lymph node; CCRT, concurrent chemoradiotherapy; RML, right middle lobe; RTx, radiotherapy; LUL, left upper lobe; CTx, chemotherapy; LLL, left lower lobe; MDR-TB, multi drug-resistant-tuberculosis.